Sandra Paci

Sandra Paci is an experienced professional in market access and patient advocacy, currently serving as the Director of Market Access & Patient Advocacy Europe at argenx since January 2019. Prior to this role, Sandra held positions including Head of Market Access at Biogen and Market Access Director for Benelux at Shire Pharmaceuticals. With extensive experience that spans various roles at Shire, Eli Lilly, Solvay Pharmaceuticals, Boehringer Ingelheim, Novartis Consumer Health, and GlaxoSmithKline, Sandra has demonstrated a strong background in regulatory affairs, pricing, reimbursement, and product management. Sandra's educational credentials include a degree from UCL.